tiprankstipranks
Trending News
More News >
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR

Compare Monopar Therapeutics Inc (MNPR) vs. Competitors

Compare
557 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Monopar Therapeutics Inc
$69.60
$465.11M
-20.24
178.62%
11 Buy
0 Hold
0 Sell
Strong Buy
Cardiff Oncology
$2.81
$189.28M
-3.54
-14.59%
6 Buy
0 Hold
0 Sell
Strong Buy
Vanda
$7.70
$455.04M
-5.38
75.80%
3 Buy
1 Hold
0 Sell
Strong Buy
Verastem
$6.79
$511.42M
-1.59
34.72%
6 Buy
0 Hold
0 Sell
Strong Buy
Mereo Biopharma Group Plc
$0.72
$114.01M
-2.72
-76.60%
6 Buy
2 Hold
0 Sell
Strong Buy
Silence Therapeutics
$5.87
$277.26M
-3.51
4.63%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MNPR
Monopar Therapeutics Inc
69.60
39.12
128.35%
CRDF
Cardiff Oncology
2.81
-0.59
-17.35%
VNDA
Vanda
7.70
3.26
73.42%
VSTM
Verastem
6.79
1.51
28.60%
MREO
Mereo Biopharma Group Plc
0.72
-2.18
-75.31%
SLN
Silence Therapeutics
5.87
0.84
16.70%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts